Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

NCT05220033 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT05220033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05220033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 14, 2020
Completion date
December 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, fallopian tube cancer, gynecologic cancer, ovarian cancer, uterine cancer